article thumbnail

AI medtech platform is aiming to tackle drug-resistant pathogens

Pharmaceutical Technology

Antimicrobial resistance is when bacteria and viruses become resistant to medication, making previous treatments ineffective. Computer-aided drug design methods have increasingly been using more AI technology, as it can “rapidly assimilate big data”, according to a GlobalData report.

Drugs 147
article thumbnail

Artificial intelligence could be new blueprint for precision drug discovery

The Pharma Data

The study findings could measurably change how researchers sift through big data to find meaningful information with significant benefit to patients, the pharmaceutical industry and the nation’s health care systems. have access to unlimited amounts of ‘big data’ and better tools than ever to analyze such data.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

The company has created a novel AI platform to develop enzymes from bacteria-killing viruses (bacteriophages) as a new way to tackle bacterial infections, and has secured €4 million investment to support its development. Obulytix is not alone.

article thumbnail

AMR: why we need to advance the discovery of new antimicrobials? 

Drug Discovery World

In 2020, a team of researchers from MIT used a machine-learning platform to identify a new antibiotic compound which was shown to kill certain strains of bacteria, including resistant-bacteria. The teams made use of the fact that many bacteria produce antibiotic peptides to fight each other.

article thumbnail

Can artificial intelligence help craft new medicines?

Drug Discovery World

The magic bullet was the drug, while the specific mark it would reach in the syphilis causing bacteria to eliminate the disease was the drug target. The drug target for Penicillin is a protein that helps bacteria to synthesise its cell wall. Big data handling and machine learning made progress by leaps.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. Last year, Novo Nordisk forged extensive global partnerships, which included teaming up with Microsoft to leverage AI and big data technology to expedite its research. billion in 2022.

Sales 98